不孕症治疗市场规模、份额和成长分析（按产品、手术、患者类型、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，不孕症治疗市场规模将达到 40.6 亿美元，到 2025 年将达到 43.4 亿美元，到 2033 年将达到 74.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 6.9%。

全球不孕症治疗市场正经历显着成长，其主要驱动因素包括不孕症上升、女性生育年龄增长、生活方式改变以及医疗技术的突破性进展。全球相当一部分人口面临不孕症的困扰，这推动了对有效且创新治疗方案的需求。辅助生殖技术（ART），例如体外受精（IVF）和卵胞浆内单一精子注射（ICSI），正逐渐成为主流选择，并受益于不断提高的成功率和患者疗效的技术进步。随着这些技术的普及和价格的降低，预计该市场将进一步扩张。此外，人们对第三方辅助生殖的接受度不断提高、可支配收入的增加以及生育年龄的变化趋势等因素，也共同推动了不孕症治疗领域的发展。

生育治疗市场驱动因素

全球不孕症的上升趋势可归因于生活方式改变、生育年龄延迟以及环境因素等。随着越来越多的个人和夫妇面临生育挑战，对各种不孕症治疗方法的需求也日益增长。此外，医疗技术的进步，特别是体外受精（IVF）和卵胞浆内单一精子注射（ICSI）等辅助生殖技术的进步，显着提高了治疗成功率，使这些治疗方法更加有效和普及。这些因素共同推动了不孕症治疗市场的成长。

限制生育治疗市场的因素

不孕症治疗市场面临的主要挑战之一是体外受精（IVF）和基因检测等先进疗法的高昂费用。这种经济负担限制了许多患者获得治疗的机会，导致很大一部分人群无法负担这些重要的治疗费用。此外，与辅助生殖技术相关的伦理困境，例如对胚胎操作的担忧以及代孕的伦理考量，也增加了市场的复杂性，并可能阻碍市场扩张。这些因素共同构成了一个限制性环境，影响着服务的可及性和整个产业的成长。

不孕症治疗市场趋势

由于消费者意识的提高和对精准医疗（尤其是体外受精（IVF）技术）的日益重视，不孕症治疗市场正经历显着增长。基因检测和筛检技术的创新变得至关重要，使得胚胎选择更加个人化成为可能，从而提高胚胎着床成功率并最大限度地降低遗传风险。此外，面临不孕症的个人和夫妇对第三方辅助生殖技术（例如代孕和配子捐赠）的接受度也呈现出显着上升的趋势。这种不断变化的格局反映了社会整体上探索多元化生育途径的意愿，并将最终塑造不孕症治疗的未来。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 监管分析
• 技术分析

全球不孕症治疗市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 装置
  • 显微镜
  • 影像系统
  • 精子分析系统
  • 卵子吸泵
  • 微型机械手臂系统
  • 培养箱
  • 气体分析仪
  • 雷射系统
  • 冷冻保存系统
  • 精子分离装置
• 文化媒体与消费品
• 配件

全球不孕症治疗市场规模（依治疗项目及复合年增长率划分）（2026-2033 年）

• 辅助生殖技术
  • 体外受精
  • 胞浆内单一精子注射
  • 代孕
• 人工授精
  • 子宫内人工授精
  • 子宫颈内人工授精
  • 输卵管内人工授精
• 不孕症治疗手术
  • 腹腔镜
  • 子宫镜检查
  • 子宫肌瘤切除术
  • 开放性手术
  • 输卵管结扎復通手术
  • 精索静脉曲张手术
  • 显微重组手术
  • 输精管再植术
  • 输精管附睪吻合术
• 其他生育治疗程序

全球不孕症治疗市场规模（依病患类型划分）及复合年增长率（2026-2033 年）

• 女性不孕症治疗
• 男性不孕症治疗

全球不孕症治疗市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 不孕症治疗中心
• 医院和外科诊所
• 精子和卵子储存库
• 研究所

全球不孕症治疗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• CooperSurgical, Inc.（USA）
• Vitrolife（Sweden）
• FUJIFILM Irvine Scientific（Japan）
• Thermo Fisher Scientific, Inc.（USA）
• Cook Medical Inc.（USA）
• Hamilton Thorne Ltd.（USA）
• Esco Micro Pte. Ltd.（Singapore）
• Genea Biomedx（Australia）
• Merck KGaA（Germany）
• Ferring Pharmaceuticals（Switzerland）
• Organon & Co.（USA）
• Abbott Laboratories（USA）
• Novartis AG（Switzerland）
• Bayer AG（Germany）
• Indira IVF（India）
• Fairhaven Health（USA）
• Theralogix（USA）
• Vitabiotics Ltd.（UK）
• Exeltis（Spain）
• Zita West（UK）

结论与建议

Infertility Treatment Market size was valued at USD 4.06 Billion in 2024 and is poised to grow from USD 4.34 Billion in 2025 to USD 7.41 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global infertility treatment market is witnessing significant growth driven by several key factors, including rising infertility rates, advancing maternal age, lifestyle changes, and breakthrough medical technologies. A substantial portion of the global population experiences infertility, fueling the demand for effective and innovative treatment solutions. Assisted Reproductive Technology (ART) methods, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have emerged as mainstream options, benefiting from continuous technological advancements that enhance success rates and patient outcomes. This market is poised for further expansion as these technologies become more accessible and affordable. Factors like the increasing acceptance of third-party reproduction, growing disposable income, and trends toward delayed parenthood also contribute to the evolving landscape of infertility treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segments Analysis

Global Infertility Treatment Market is segmented by Product, Procedure, Patient Type, End User and region. Based on Product, the market is segmented into Equipment, Media & Consumables and Accessories. Based on Procedure, the market is segmented into Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries and Other Infertility Treatment Procedures. Based on Patient Type, the market is segmented into Female Infertility Treatment and Male Infertility Treatment. Based on End User, the market is segmented into Fertility Centers, Hospitals & Surgical Clinics, Cryobanks and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infertility Treatment Market

The increasing prevalence of infertility on a global scale can be attributed to factors such as lifestyle changes, postponed parenthood, and environmental influences. This rise in the number of individuals and couples facing fertility challenges has led to a growing demand for a variety of infertility treatment options. Additionally, advancements in medical technology, particularly in assisted reproductive techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have markedly improved success rates, thereby making these treatments more effective and accessible. Collectively, these elements are driving the growth of the infertility treatment market.

Restraints in the Infertility Treatment Market

A significant challenge facing the infertility treatment market is the high cost associated with advanced therapies like in vitro fertilization (IVF) and genetic testing. These financial burdens limit access for many individuals, making it difficult for a large segment of the population to afford these essential treatments. In addition, ethical dilemmas surrounding assisted reproductive technologies-such as concerns over embryo manipulation and the moral considerations of surrogacy-add layers of complexity that can hinder market expansion. These factors contribute to a constrained environment, affecting both the accessibility of services and overall growth within the sector.

Market Trends of the Infertility Treatment Market

The infertility treatment market is experiencing significant growth driven by rising consumer awareness and an increased emphasis on precision medicine, particularly in in vitro fertilization (IVF) techniques. Genetic testing and screening innovations are becoming essential, facilitating more personalized embryo selection that enhances the chances of successful implantation while minimizing genetic risks. Additionally, there is a notable trend towards the acceptance and utilization of third-party reproductive methods, such as surrogacy and gamete donation, which are gaining traction among individuals and couples navigating infertility challenges. This evolving landscape reflects a broader societal willingness to explore diverse pathways to parenthood, ultimately shaping the future of infertility treatment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis
• Technology Analysis

Global Infertility Treatment Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
• Media & Consumables
• Accessories

Global Infertility Treatment Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Assisted Reproductive Technology
  • In Vitro Fertilization
  • Intracytoplasmic Sperm Injection
  • Surrogacy
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
• Fertility Surgeries
  • Laparoscopy
  • Hysteroscopy
  • Myomectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Varicocelectomy
  • Microsurgical Reconstruction
  • Vasovasostomy
  • Vasoepididymostomy
• Other Infertility Treatment Procedures

Global Infertility Treatment Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Female Infertility Treatment
• Male Infertility Treatment

Global Infertility Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Centers
• Hospitals & Surgical Clinics
• Cryobanks
• Research Institutes

Global Infertility Treatment Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Patient Type, End User)
  • US
  • Canada
• Europe (Product, Procedure, Patient Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure, Patient Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure, Patient Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Patient Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Micro Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Biomedx (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indira IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fairhaven Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theralogix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitabiotics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exeltis (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zita West (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations